Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Code:
NCT05809752
Conditions
Leptomeningeal Disease
Triple Negative Breast Cancer
HER2-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dendritic Cell Vaccine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute on 2025-03-13.